» Articles » PMID: 39330261

Exploring the Antimicrobial Potential of Hallachrome, a Defensive Anthraquinone from the Marine Worm (Polychaeta)

Overview
Journal Mar Drugs
Publisher MDPI
Specialties Biology
Pharmacology
Date 2024 Sep 27
PMID 39330261
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial resistance is a critical global health issue, with rising resistance among bacteria and fungi. Marine organisms have emerged as promising, but underexplored, sources of new antimicrobial agents. Among them, marine polychaetes, such as , which possess chemical defenses, could attract significant research interest. This study explores the antimicrobial properties of hallachrome, a unique anthraquinone found in the purple mucus of , against Gram-negative bacteria ( ATCC 25922, ATCC 9027), Gram-positive bacteria ( ATCC 29212, ATCC 6538, ATCC 12228), and the most common human fungal pathogen ATCC 10231. Antibacterial susceptibility testing revealed that Gram-negative bacteria were not inhibited by hallachrome at concentrations ≤2 mM. However, Gram-positive bacteria showed significant growth inhibition at 0.12-0.25 mM, while was inhibited at 0.06 mM. Time-kill studies demonstrated dose-dependent growth inhibition of susceptible strains by hallachrome, which exerted its effect by altering the membrane permeability of , , and after 6 h and after 24 h. Additionally, hallachrome significantly reduced biofilm formation and mature biofilm in , , and . Additionally, it inhibited hyphal growth in . These findings highlight hallachrome's potential as a novel antimicrobial agent, deserving further exploration for clinical experimentation.

References
1.
Nwobodo D, Ugwu M, Oliseloke Anie C, Al-Ouqaili M, Ikem J, Victor Chigozie U . Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. J Clin Lab Anal. 2022; 36(9):e24655. PMC: 9459344. DOI: 10.1002/jcla.24655. View

2.
Ma W, Liu C, Li J, Hao M, Ji Y, Zeng X . The effects of aloe emodin-mediated antimicrobial photodynamic therapy on drug-sensitive and resistant Candida albicans. Photochem Photobiol Sci. 2020; 19(4):485-494. DOI: 10.1039/c9pp00352e. View

3.
Newman D, Cragg G . Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007; 70(3):461-77. DOI: 10.1021/np068054v. View

4.
Gauwerky K, Borelli C, Korting H . Targeting virulence: a new paradigm for antifungals. Drug Discov Today. 2009; 14(3-4):214-22. DOI: 10.1016/j.drudis.2008.11.013. View

5.
Mayer F, Wilson D, Hube B . Candida albicans pathogenicity mechanisms. Virulence. 2013; 4(2):119-28. PMC: 3654610. DOI: 10.4161/viru.22913. View